In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

Thousands of people who used a weight-loss supplement will be receiving a portion of more than $400,000, according to the ...

Patients on high doses of a popular weight-loss drug shed fewer pounds than those on a lower dose, a study has found.

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...

A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...

A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

Cipla expands into CNS and weight management segments, focusing on patient needs and innovation for long-term value.

Ongoing research is needed to fully understand their risks, especially for long-term and higher-dose users. However, many ...

Amanda Bynes was seen stepping out in Malibu over the weekend after getting candid about her Ozempic weight loss journey.

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent muscle loss in these patients, according to a small ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...